The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MCHP, TGTX, MGTI, HAS, CPB and ADNT

NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) — The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.      

Microchip Technology Inc. (NASDAQGS: MCHP)
Class Period: March 2, 2018 to August 9, 2018
Lead Plaintiff Deadline: November 16, 2018

The lawsuit alleges that Microchip Technology Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Microsemi’s financial performance was underperforming Microchip’s expectations; and (2) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, including positive statements about Microsemi, were materially misleading and/or lacked a reasonable basis.

Get additional information about the MCHP lawsuit: http://www.kleinstocklaw.com/pslra-1/microchip-technology-inc-loss-submission-form?wire=3

TG Therapeutics, Inc. (NASDAQCM: TGTX)
Class Period: June 4, 2018 to September 25, 2018
Lead Plaintiff Deadline: December 3, 2018

According to the complaint, TG Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) TG was involved in cleaning the data collected in the UNITY-CLL Trial; and as a result, was able to gain an understanding as to the efficacy of the combination therapy; (2) as a result of that data cleaning, TG knew the UNITY-CLL Trial had failed to meet its stated goal and as a result, the Company would not be able to seek accelerated approval; and (3) given that the UNITY-CLL Trial had failed to meet its stated goal, it was highly unlikely that the combination therapy would meet its primary endpoint of increased progression free survival.

Get additional information about the TGTX lawsuit: http://www.kleinstocklaw.com/pslra-1/tg-therapeutics-inc-loss-submission-form?wire=3

MGT Capital Investments Inc. (OTCMKTS: MGTI)
Class Period: October 9, 2015 to September 7, 2018
Lead Plaintiff Deadline: November 27, 2018

MGT Capital Investments Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Defendants were engaged in an illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (2) the “Scheme Defendants”–Defendants Ladd, Honig, Stetson, Brauser, O’Rourke, and Groussman–had a history of engaging in illegal conduct in connection with the purchase and sale of securities; (3) the Scheme Defendants were a “group”, pursuant to Section 13 of the Exchange Act; (4) the Scheme Defendants exercised control over the Company; (5) the Company’s acquisition of D-Vasive Inc. was part of Defendants’ illegal pump-and-dump scheme to artificially inflate MGT Capital’s stock price; (6) Defendants’ illicit scheme caused MGT Capital to make false and misleading statements, which would result in governmental and regulatory scrutiny; (7) the scheme would result in the delisting of MGT Capital’s stock from NYSE MKT; and (8) as a result, Defendants’ statements about MGT Capital’s business and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the MGTI lawsuit: http://www.kleinstocklaw.com/pslra-1/mgt-capital-investments-inc-loss-submission-form?wire=3

Hasbro, Inc. (NASDAQGS: HAS)
Class Period: April 24, 2017 to October 23, 2017
Lead Plaintiff Deadline: November 27, 2018

The lawsuit alleges that throughout the class period, Hasbro, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Hasbro’s relationship with Toys “R” Us was becoming increasingly important to Hasbro’s business, as Toys “R” Us was the primary retail brick-and-mortar toy store in the United States; (2) Toys “R” Us was in far worse financial condition than was being publicly reported and it would have to dramatically scale back its operations or file for bankruptcy and liquidate; and (3) Hasbro was experiencing significant adverse sales issues in the key markets of the United Kingdom and Brazil which were negatively impacting the Company’s efforts to grow sales in those markets.

Get additional information about the HAS lawsuit: http://www.kleinstocklaw.com/pslra-1/hasbro-inc-loss-submission-form?wire=3

Campbell Soup Company (NYSE: CPB)
Class Period: August 31, 2017 to May 17, 2018
Lead Plaintiff Deadline: November 27, 2018

The complaint alleges that throughout the class period Campbell Soup Company made materially false and/or misleading statements and/or failed to disclose that: (1) the defendants failed to disclose known trends that were negatively impacting the profitability of the Campbell Fresh division; and (2) as a result of the foregoing, the defendants’ positive statements about Campbell’s and the Campbell Fresh division’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Get additional information about the CPB lawsuit: http://www.kleinstocklaw.com/pslra-1/campbell-soup-company-loss-submission-form?wire=3

Adient plc (NYSE: ADNT)
Class Period: October 31, 2016 to June 11, 2018
Lead Plaintiff Deadline: December 3, 2018

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements. In particular, the complaint alleges that defendants repeatedly stressed to investors that the Company was “solidly on track” to deliver 200-basis-point margin expansion by 2020, which was largely dependent on operational and financial improvements in Adient’s core SS&M business, while unbeknownst to investors, Adient’s core SS&M business faced significant operational problems such that the repeatedly touted 200-basis-point margin expansion was not “on track” at any point during the Class Period. Consequently, Adient stock traded at artificially inflated prices during the Class Period, reaching a high of $85.93 per share.

Get additional information about the ADNT lawsuit: http://www.kleinstocklaw.com/pslra-1/adient-plc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com